Università degli Studi della Campania Luigi Vanvitelli, Italy
Twitter: @LuciaAltucci
Specialisms: Epigenetics, Cancer, Programmed cell death, Signal transduction, Innovative therapies
Università degli Studi della Campania Luigi Vanvitelli, Italy
Twitter: @LuciaAltucci
Specialisms: Epigenetics, Cancer, Programmed cell death, Signal transduction, Innovative therapies
University Medical Center Groningen, The Netherlands
Specialisms: Epigenetics, Epigenetic editing
Rui Henrique, Portuguese Oncology Institute of Porto and Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal
Holger Heyn, National Center for Genomic Analysis, Center for Genomic Regulation (CNAG-CRG), Barcelona Institute of Science and Technology (BIST), Spain
Hendrik (Henk) G Stunnenberg, Princess Máxima Center for Pediatric Oncology, Utrecht and Radboud University Nijmegen, The Netherlands
CNRS - Institut Pasteur, France
Twitter: @PbaEpiCBio1
Section: Epigenetic therapies and clinical trials
Specialisms: Chemical biology, Epigenetics, DNA, Histone
Monash University, Australia
Twitter: @SamElOsta1
Section: Endocrinology and metabolic epigenetics
Specialisms: Epigenetics, DNA methylation, Chromatin, Histones, Gene Regulation, Human Disease, Cardiovascular Disease, T1D
St James's Hospital, Ireland
Section: Environmental epigenetics
Specialisms: Lung Cancer, Mesothelioma, Biomarker, Epigenetics
University of Southampton, United Kingdom
Twitter: @ProfJWHolloway
Section: Respiratory Epigenetics
Specialisms: Asthma, Allergy, Respiratory, Genomics, Epigenetics
University of Porto, Portugal
Twitter: @GEBC_IPOPorto
Section: Cancer epigenetics and diagnostics
Specialisms: Cancer Epigenetics, Cancer epitranscriptomics, Biomarkers, Epidrugs, Molecular pathology, Precision oncology
Pomeranian Medical University in Szczecin, Poland
Section: Epigenetic biomarkers
Specialisms: Epigenetics, Methylation, Cancer, Biomarker, diagnosis, IVD
Maria Berdasco, Joseph Carreras Leukemia Research Institute (IJC), Spain
Section: Cancer epigenetics and diagnostics
Jim Davie, University of Manitoba, Canada
Section: Epigenetic technologies
Georges Herbein, University of Franche-Comté, France
Section: Allergy, immunology, pathogens and inflammation
Jonathan Licht, The University of Florida, USA
Section: Cancer Epigenetics – Haematological Malignancies
Eamonn Maher, University of Cambridge, UK
Section: Reproductive and transgenerational epigenetics
Jonathan Mill, University of Exeter and King's College London, UK
Section: Neurology and psychiatry epigenetics
Adele Murrell, University of Bath, UK
Section: Regenerative medicine
Ronan Murphy, Dublin City University, Ireland
Section: Cardiovascular epigenetics
Moshe Szyf, McGill University, Canada
Section: Neurology and psychiatry epigenetics
Akihiro Umezawa, National Institute for Child Health & Development, Japan
Section: Aging and development epigenetics
Nita Ahuja, Yale University, USA
Section: Cancer epigenetics and diagnostics
Miguel Constancia, University of Cambridge, UK
Section: Reproductive and transgenerational epigenetics
Dawn L. DeMeo, Brigham and Women's Hospital/ Harvard Medical School, USA
Section: Respiratory Epigenetics
James M Flanagan, Imperial College London, UK
Section: Cancer epigenetics and diagnostics
Mario F Fraga, Nanomaterials and Nanotechnology Center (CINN-CSIC), Health Research Institute of Asturias (ISPSA), Institute of Oncology of Asturias (IUOPA, University of Oviedo), Spain
Section: Cancer epigenetics and diagnostics
Michèle J Hoffmann, Heinrich-Heine-University Duesseldorf, Germany
Section: Cancer epigenetics and diagnostics
Albert Jeltsch, University of Stuttgart, Germany
Section: Epigenetic technologies
Bozena Kaminska, Nencki Institute of Experimental Biology, Poland
Section: Cancer epigenetics and diagnostics
Nishino Koichiro, University of Miyazaki, Japan
Section: Aging and development epigenetics
Nick La Thangue, University of Oxford, UK
Section: Epigenetic therapies and clinical trials
Charlotte Ling, Lund University, Sweden
Section: Endocrinology and metabolic epigenetics
Gwen Lomberk, Medical College of Wisconsin, USA
Section: Cancer epigenetics and diagnostics
Lingeng Lu, Yale University, USA
Section: Statisticians
Antonello Mai, "Sapienza" Universitá di Roma, Italy
Section: Epigenetic therapies and clinical trials
Riccardo Marioni, University of Edinburgh, UK
Section: Neurology and psychiatry epigenetics
Joost Martens, Radboud Institute for Molecular Life Sciences, The Netherlands
Section: Cancer Epigenetics – Haematological Malignancies
Richard Momparler, University of Montreal, Canada
Section: Epigenetic therapies and clinical trials
Kari Nadeau, Stanford University, USA
Section: Allergy, immunology, pathogens and inflammation
Boris Novakovic, Murdoch Children's Research Institute, Australia
Section: Environmental epigenetics
Arpad Patai, Semmelweis University, Hungary
Section: Cancer epigenetics and diagnostics
Monika Puzianowska-Kuznicka, Mossakowski Medical Research Centre, Poland
Section: Aging and development epigenetics
Peter Rugg-Gunn, The Babraham Institute, University of Cambridge, UK
Section: Regenerative medicine
Richard Saffery, Murdoch Children’s Research Institute, Australia
Section: Endocrinology and metabolic epigenetics
David Jay Segal, University of California-Davis, USA
Section: Innovative epigenetic therapies
Harold Snieder, University Medical Center Groningen, The Netherlands
Section: Epigenetic biomarkers, Statisticians
Qian Tao, The Chinese University of Hong Kong, Hong Kong
Section: Cancer epigenetics and diagnostics
Andrew Teschendorff, Chinese Academy of Sciences and Max-Planck Partner Institute for Computational Biology, CAS, China
Section: Epigenetic biomarkers
Jonathan Turner, Luxembourg Institute of Health, Luxembourg
Section: Neurology and psychiatry epigenetics
Raul Urrutia, Genomics Sciences and Precision Medicine Center, Medical College of Wisconsin, USA
Section: Cancer epigenetics and diagnostics
Saad Z Usmani, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Section: Cancer Epigenetics – Haematological Malignancies
Wim Vanden Berghe, University of Antwerp, Belgium
Section: Lifestyle epigenetics
Wolfgang Wagner, Aachen University Medical School, Germany
Section: Agin
Stefan Wiemann, German Cancer Research Center-Heidelberg (DKFZ), Germany
Section: Cancer epigenetics and diagnostics
Keishi Yamashita, Kitasato University, Japan
Section: Cancer epigenetics and diagnostics
Lorena Aguilar Arnal, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, México
Alfonso Baldi, Università della Campania Luigi Vanvitelli, Italy
Steven Belinsky, Lovelace Respiratory Research Institute, USA
Rosaria Benedetti, Universitá degli Studi della Campania "Luigi Vanvitelli", Italy
Nathalie Bérubé, Western University, Canada
Pilar Blancafort, The Harry Perkins Institute of Medical Research & University of Western Australia, Australia
Tiziana Bonaldi, European Institute of Oncology, Italy
Miguel Branco, Queen Mary University of London, UK
Robert Brown, Imperial College London, UK
Kyle J Burghardt, Wayne State University, USA
Andres Cardenas, University of California, Berkeley, USA
Katherine Chiappinelli, George Washington University, USA
James Chim, University of Hong Kong, Hong Kong
Gianluigi Condorelli, Humanitas University, Italy
Rene Cortese, University of Missouri, USA
Christos Damaskos, University of Athens, Greece
Soner Dogan, Yeditepe University, Turkey
Thomas Eggermann, RWTH Aachen, Germany
Karl Ekwall, Karolinska Institutet, Sweden
Frank O Fackelmayer, Institute of Molecular Biology and Biotechnology IMBB-Forth, Greece
Mirco Fanelli, University of Urbino "Carlo Bo," Italy
Robert Feil, CNRS and University of Montpellier, France
Roger Foo, Genome Institute of Singapore, Singapore
François Fuks, Université libre de Bruxelles, Belgium
Peter Gluckman, The Liggins Institute of Medical Research, New Zealand
Antonio Gómez, University of Vic – Central University of Catalonia, Spain
Joel Gottesfeld, The Scripps Research Institute, USA
Monika Hegi, Lausanne University Hospital, Switzerland
Ricky Johnstone, Peter MacCallum Cancer Centre, Australia
Meaghan Jones, The University of British Columbia, Canada
Renata Jurkowska, Cardiff University, UK
Masayo Kagami, National Research Institute for Child Health and Development, Japan
Yutaka Kondo, Nagoya City University Graduate School of Medical Sciences, Japan
Ah-Ng Tony Kong, Rutgers University, USA
Michele A La Merrill, University of California-Davis, USA
Andy Lau, Shantou University Medical College, China
Haitao Li, Tsinghua University, China
Lili Li, The Chinese University of Hong Kong, Hong Kong
Michael Lübbert, Universitätsklinikum Freiburg, Germany
Deborah JG Mackay, Southampton University Hospital, UK
Patrick O McGowan, University of Toronto, Canada
Saverio Minucci, IFOM - IEO, Italy
David Monk, Institut d'Investigació Biomèdica Bellvitge, Spain
Pamela Munster, University of California, USA
Clara Nervi, University of Rome La Sapienza, Italy
Andreas Neubauer, Philipps Universität Marburg, Germany
Stephen Nimer, University of Miami, USA
Miina Ollikainen, University of Helsinki, Finland
Jan Postberg, Witten/Herdecke University, Germany
H Llewelyn Roderick, KU Leuven, Belgium
Olivier Rohr, University of Strasbourg, France
Lucas A Salas, Geisel School of Medicine at Dartmouth College, USA
Paola Scaffidi, The Francis Crick Institute and UCL Cancer Institute, UK
Huidong Shi, Georgia Cancer Center, Medical College of Georgia, Augusta University, USA
Toshihiro Shioda, Massachusetts General Hospital Center for Cancer Research and Harvard Medical School, USA
Gustavo Turecki, McGill University, Canada
Toshikazu Ushijima, National Cancer Center Research Institute, Japan
Carine Van Lint, University of Brussels (ULB), Belgium
Eric Verdin, J David Gladstone Institutes, USA
Aleksandar Vojta, University of Zagreb, Croatia
Bea Wisman, University Medical Center Groningen, The Netherlands
Olaf Witt, German Cancer Research Center, Germany
Suowen Xu, University of Science and Technology of China, China
Elisabeth Zeisberg, University Medical Center Göttingen, Germany
Vlatka Zoldos, University of Zagreb, Croatia